创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

艾司氯胺酮联合全身麻醉及腹横肌平面阻滞在肥胖患者行腹腔镜手术中的应用研究

Application Research of Esketamine Combined with General Anesthesia and Transversus Abdominis Plane Block for Obese Patients Undergoing Laparoscopic Surgery

  • 摘要: 目的 研究肥胖患者在行腹腔镜手术中采用艾司氯胺酮联合全身麻醉及腹横肌平面阻滞(transversus abdominis planeblock,TAPB)的应用效果。方法 选择随机数表法将淮北市人民医院于2023年1月至2025年2月接收的100例肥胖腹腔镜手术患者,分为研究组(采用艾司氯胺酮联合全身麻醉及TAPB)和对照组(采用全身麻醉联合TAPB),均为50例。比较2组患者的血流动力学指标、苏醒质量、术后动态及静态视觉模拟疼痛评分(Visual Analogue Scale,VAS)和24 h内的镇痛补救率,以及40项恢复质量评分量表(40-item Quality of Recovery Scale,QoR-40)、应激反应指标和不良反应。结果 与对照组相比,研究组气腹建立后和切皮后的收缩压、舒张压较低,心率较慢(P < 0.05),但2组数值较麻醉诱导前增大(P < 0.05)。与对照组相比,研究组的自主呼吸恢复时间、苏醒时间和拔管时间较早,术后动态及静态VAS评分、镇痛补救率较低,术后24 h的QoR-40评分较高(P < 0.05)。与对照组相比,研究组在术后24 h应激反应指标数值较低(P < 0.05),但2组均高于术前(P < 0.05)。2组不良反应率差异无统计学意义(P > 0.05)。结论 艾司氯胺酮联合全身麻醉及TAPB能减少肥胖患者腹腔镜手术中血流动力学波动,减轻患者术后疼痛,促进苏醒,缓解应激反应,且具备安全性。

     

    Abstract: Objective To investigate the effect of esketamine combined with general anesthesia and transversus abdominis plane block (TAPB) in obese patients undergoing laparoscopic surgery. Methods A total of 100 obese patients scheduled for laparoscopic surgery at Huaibei People's Hospital from January 2023 to February 2025 were assigned, using a random number table, to either an intervention group (esketamine combined with general anesthesia and TAPB) or a control group (general anesthesia combined with TAPB), with 50 cases in each. The hemodynamics, recovery quality, postoperative dynamic and static Visual Analogue Scale (VAS) pain scores, and the analgesic rescue rate within 24 hours, the 40-item Quality of Recovery Scale (QoR-40) at 24 hours postoperatively, stress response indicators, and adverse reactions were compared between the two groups. Results Compared with the control group, the systolic and diastolic blood pressures of the intervention group after pneumoperitoneum establishment and skin incision were lower, and the heart rate was slower (P < 0.05), but the values of both groups were increased compared to before anesthesia induction levels (P < 0.05). The intervention group also demonstrated earlier recovery of spontaneous breathing, earlier time to awakening and extubation, lower postoperative dynamic and static VAS scores, a lower 24-hour analgesic rescue rate, and higher QoR-40 scores at 24 hours postoperatively (P < 0.05). Stress response indicators at 24 hours postoperatively were lower in the intervention group than in the control group (P < 0.05), though they remained elevated above preoperative values in both groups (P < 0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion For obese patients undergoing laparoscopic surgery, the combination of esketamine with general anesthesia and TAPB can stabilize intraoperative hemodynamics, alleviate postoperative pain, enhance recovery quality, attenuate the surgical stress response, and demonstrate a favorable safety profile.

     

/

返回文章
返回